medigraphic.com
SPANISH

Revista Cubana de Urología

ISSN 2305-7939 (Electronic)
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2021, Number 1

<< Back Next >>

RCU 2021; 10 (1)

Selective arterial embolization of complicated renal angiomyolipoma

de la Cruz OA, Vázquez LF, Sarmiento DR, Quintana RM
Full text How to cite this article

Language: Spanish
References: 13
Page: 1-10
PDF size: 465.70 Kb.


Key words:

angiomyolipoma, complications, embolization, tuberous sclerosis, angiography.

ABSTRACT

Angiomyolipoma is a solid benign renal tumor that occurs most often in women. It usually occurs in middle age. Macroscopic hematuria and flank pain are non-specific symptoms. Computed axial tomography and nuclear magnetic resonance imaging have a high diagnostic sensitivity. Wunderlich syndrome (spontaneous perirenal bleeding) is its most feared complication. The selective arterial embolization turns out to be the choice treatment. The aim of this work is to describe two cases of angiomyolipomas treated by selective arterial embolization. Both patients are diagnosed with complicated renal angiomyolipoma with spontaneous rupture and hematoma. This type of tumor occurs rarely or as part of other congenital diseases. The most serious and common complication is intratumoral or retroperitoneal bleeding. Selective arterial embolization is an alternative to minimally invasive treatment and it is effective and safe when the patient mantains hemodynamic stability.


REFERENCES

  1. Bardin F, Chevallier O, Bertaut A, Delorme E, Moulin M, Pottecher P. Selective arterial embolization of symptomatic and asymptomatic renal angiomyolipomas: a retrospective study of safety, outcomes and tumor size reduction. Quant Imaging Med Surg. 2017 [acceso 21/05/2020];7(1):8-23. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5337195/

  2. Lin L, Li X, Guan H, Wang J, Tong X, Yang. Renal function, complications, and outcomes of a reduction in tumor size after transarterial embolization for renal angiomyolipomas: a meta-analysis. J Int Med Res. 2019 [acceso 21/05/2020];47(4):1417-28. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6460598/

  3. Del Toro Figueredo Y, González León T, Quintana Rodríguez M, Cruz de Oña A. A propósito de dos casos de angiomiolipoma renal. Rev Cub Urol. 2019 [acceso 15/01/2020];8(2):141-8. Disponible en: http://www.revurologia.sld.cu/index.php/rcu/article/view/515/603

  4. Seyam RM, Alkhudair WK, Kattan SA, Alotaibi MF, Alzahrani HM, Altaweel WM. The Risks of Renal Angiomyolipoma: Reviewing the Evidence. J Kidney Cancer and VHL. 2017 [acceso 15/01/2020];4(4):13-25. Disponible en: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5644357

  5. Vega-Castro R, García-Vásquez RA, Arriaga-Aguilar J, López-Chente-Casado J, Avechuco-Carrillo ZG, Blas-Reina A. Angiomiolipoma renal múltiple bilateral asociado a esclerosis tuberosa. Reporte de caso y revisión de la literatura. Rev Mex Urol. 2014 [acceso 15/01/2020];74(6):364-7. Disponible en: https://www.elsevier.es/es-revista-revista-mexicana-urologia-302-articulo-angiomiolipoma-renal-multiple-bilateral-asociado-S2007408514000263

  6. Bissler JJ, Kingswood JC. Optimal treatment of tuberous sclerosis complex associated renal angiomyolipomata: a systematic review. Ther Adv Urol. 2016 [acceso 15/01/2020];8(4):279-90. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5131738

  7. Liu F, Yuan H, Li X, Tang J, Tian X, Ji K. A new management strategy for renal angiomyolipomas: superselective arterial embolization in combination with radiofrequency ablation. Ann Transl Med. 2019 [acceso 15/01/2020];7(23):766. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6990007/

  8. Kingswood JC, Belousova E, Benedik MP, Carter T, Cottin V, Curatolo P. Renal angiomyolipoma in patients with tuberous sclerosis complex: findings from the TuberOus SClerosis registry to increase disease Awareness. Nephrol Dial Transplant. 2019 [acceso 15/01/2020];34(3):502-8. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6399480/

  9. Northrup H, Krueger DA, Roth J, Leclezio L, De Vries PJ, Teng JMC. International tuberous sclerosis complex Consensus group: tuberous sclerosis complex surveillance and management: recommendations of the 2012 international tuberous sclerosis complex Consensus conference. Pediatric Urol. 2013 [acceso 15/01/2020];49:255-65. Disponible en: http://www.tscinternational.org/international-tsc-consensus-guidelines

  10. 10 Barrufet Solé M, Medrano Peña J, Mainar Turón A, Ángel de Gregorio M, Ariza. Barrufet M. Hallazgos radiológicos de un angiomiolipoma renal con pseudoaneurisma gigante y hemorragia perirrenal espontánea. A propósito de un caso. Intervencionismo. 2009 [acceso 15/01/2020];9(3):116-20. Disponible en: http://revistaintervencionismo.com/wp-content/uploads/20093caso_clinico3.pdf

  11. Li D, Pua BB, Madoff DC. Role of embolization in the treatment of renal masses. Semin Intervent Radiol. 2014 [acceso 15/01/2020];31(1):70-81. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3930649/

  12. Kocakgol DO, Cayli E, Oguz S, Dinc H. Selective Arterial Embolization of Giant Renal Angiomyolipoma Associated with Tuberous Sclerosis Complex Using Particular and Liquid Embolic Agents. Eurasian J Med. 2018 [acceso 15/01/2020];50(2):130-3. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6039148/

  13. Haber Jeha SA, Pinheiro de Oliveira C, Santos dos Santos DA. Embolization of Ruptured Renal Angiomyolipoma in Puerpera. Rev Bras Ginecol Obstet. 2019 [acceso 15/01/2020];41(3):199-202. Disponible en: https://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-72032019000300199




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

RCU. 2021;10